Subscribe to: Magazine Email Newsletter RSS Feed LinkedIn Twitter

IN THE NEWS
  Print   

Oragenics May Sell or License Mouthrinse

2006-11-15 | 10:13

Biotechnology company Oragenics Inc. said Wednesday it hopes to sell or license its oral probiotic mouthrinse technology to allow the company to focus on research and development for its antibiotic candidate MU1140.

The company said the oral probiotic mouthrinse, called Probiora3, met its goal of reducing disease-causing bacteria, responsible for plaque and gingivitis, in a clinical trial.

Oragenics, based in Alachua, FL, focuses on developing oral health care products.

<November>
SMTWTFS
   1234
567891011
12131415161718
19202122232425
2627282930  
Back to latest news

Buyer's Guide

Search the Buyer's Guide for a company:

Search the Buyer's Guide for a category:

Search the Buyer's Guide for a term:

This will search both companies and categories


Please visit our Sister Sites:

    

Copyright © 2009 Rodman Publishing / HAPPI. All Rights Reserved. All rights reserved. Use of this constitutes acceptance of our Privacy Policy
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Publishing / HAPPI.